Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

  • Dimitrios Makrakis,
  • Konstantinos Rounis,
  • Alexandros-Pantelis Tsigkas,
  • Alexandra Georgiou,
  • Nikolaos Galanakis,
  • George Tsakonas,
  • Simon Ekman,
  • Chara Papadaki,
  • Alexia Monastirioti,
  • Meropi Kontogianni,
  • Ioannis Gioulbasanis,
  • i Mavroudis,
  • Sofia Agelaki

An additional affiliation is missing for the second author. Konstantinos Rounis is also affiliated with: Laboratory of Translational Oncology, Medical School, University of Crete.

The correct affiliations are as follows: Dimitrios Makrakis1,2, Konstantinos Rounis1,3,4, Alexandros-Pantelis Tsigkas5, Alexandra Georgiou5, Nikolaos Galanakis6, George Tsakonas3,7, Simon Ekman3,7, Chara Papadaki4, Alexia Monastirioti4, Meropi Kontogianni5, Ioannis Gioulbasanis8, Dimitris Mavroudis1,4, Sofia Agelaki1,4

1 Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece, 2 Jacobi Medical Center, Albert Einstein College of Medicine, The Bronx, NY, United States of America, 3 Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden, 4 Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece, 5 Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, 6 Department of Medical Imaging, University General Hospital, Heraklion, Crete, Greece, 7 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, 8 Department of Medical Oncology, Animus Kyanus Stavros General Clinic, Larissa, Greece

Reference

  1. 1. Makrakis D, Rounis K, Tsigkas AP, Georgiou A, Galanakis N, Tsakonas G, et al. (2023) Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS ONE 18(2): e0277708. https://doi.org/10.1371/journal.pone.0277708 pmid:36763597